Log in

NASDAQ:UTMD - Utah Medical Products Stock Price, Forecast & News

+0.83 (+0.86 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
Now: $96.93
50-Day Range
MA: $98.80
52-Week Range
Now: $96.93
Volume10,596 shs
Average Volume9,463 shs
Market Capitalization$360.58 million
P/E Ratio24.60
Dividend Yield1.17%
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
Current SymbolNASDAQ:UTMD



Sales & Book Value

Annual Sales$46.90 million
Cash Flow$5.01 per share
Book Value$23.83 per share


Net Income$14.73 million


Market Cap$360.58 million
Next Earnings Date4/23/2020 (Estimated)
OptionableNot Optionable

Receive UTMD News and Ratings via Email

Sign-up to receive the latest news and ratings for UTMD and its competitors with MarketBeat's FREE daily newsletter.

Utah Medical Products (NASDAQ:UTMD) Frequently Asked Questions

What is Utah Medical Products' stock symbol?

Utah Medical Products trades on the NASDAQ under the ticker symbol "UTMD."

How often does Utah Medical Products pay dividends? What is the dividend yield for Utah Medical Products?

Utah Medical Products declared a quarterly dividend on Thursday, February 13th. Investors of record on Friday, March 13th will be given a dividend of $0.28 per share on Thursday, April 2nd. This represents a $1.12 dividend on an annualized basis and a yield of 1.16%. The ex-dividend date of this dividend is Thursday, March 12th. View Utah Medical Products' Dividend History.

How were Utah Medical Products' earnings last quarter?

Utah Medical Products, Inc. (NASDAQ:UTMD) announced its quarterly earnings results on Thursday, January, 30th. The medical instruments supplier reported $1.01 EPS for the quarter. The medical instruments supplier had revenue of $11.83 million for the quarter. Utah Medical Products had a return on equity of 15.10% and a net margin of 31.40%. View Utah Medical Products' Earnings History.

When is Utah Medical Products' next earnings date?

Utah Medical Products is scheduled to release their next quarterly earnings announcement on Thursday, April 23rd 2020. View Earnings Estimates for Utah Medical Products.

Has Utah Medical Products been receiving favorable news coverage?

Headlines about UTMD stock have been trending very negative this week, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Utah Medical Products earned a news sentiment score of -3.5 on InfoTrie's scale. They also gave media coverage about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for Utah Medical Products.

Are investors shorting Utah Medical Products?

Utah Medical Products saw a decline in short interest in January. As of January 31st, there was short interest totalling 118,500 shares, a decline of 5.7% from the January 15th total of 125,700 shares. Based on an average trading volume of 9,800 shares, the days-to-cover ratio is currently 12.1 days. Approximately 3.4% of the company's stock are sold short. View Utah Medical Products' Current Options Chain.

Who are some of Utah Medical Products' key competitors?

What other stocks do shareholders of Utah Medical Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Utah Medical Products investors own include Altria Group (MO), UnitedHealth Group (UNH), Gilead Sciences (GILD), Prothena (PRTA), Trupanion (TRUP), Walgreens Boots Alliance (WBA), Avery Dennison (AVY), Franklin Resources (BEN), Quest Diagnostics (DGX) and Eastman Chemical (EMN).

Who are Utah Medical Products' key executives?

Utah Medical Products' management team includes the folowing people:
  • Mr. Kevin L. Cornwell, Chairman, CEO, Pres & Sec. (Age 72)
  • Mr. Brian L. Koopman, Principal Financial Officer & Controller

Who are Utah Medical Products' major shareholders?

Utah Medical Products' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include FMR LLC (11.71%), Renaissance Technologies LLC (6.29%), Russell Investments Group Ltd. (4.39%), ProShare Advisors LLC (3.19%), Rice Hall James & Associates LLC (2.17%) and State Street Corp (2.09%). Company insiders that own Utah Medical Products stock include Barbara A Payne, Brian Koopman, Ernst G Hoyer and Kevin L Cornwell. View Institutional Ownership Trends for Utah Medical Products.

Which major investors are selling Utah Medical Products stock?

UTMD stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Morgan Dempsey Capital Management LLC, THB Asset Management, Wedge Capital Management L L P NC, US Bancorp DE, AQR Capital Management LLC, Renaissance Technologies LLC and Loomis Sayles & Co. L P. Company insiders that have sold Utah Medical Products company stock in the last year include Barbara A Payne, Brian Koopman and Kevin L Cornwell. View Insider Buying and Selling for Utah Medical Products.

Which major investors are buying Utah Medical Products stock?

UTMD stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., ProShare Advisors LLC, State Street Corp, Rice Hall James & Associates LLC, Goldman Sachs Group Inc., UBS Group AG, Barclays PLC and Denali Advisors LLC. View Insider Buying and Selling for Utah Medical Products.

How do I buy shares of Utah Medical Products?

Shares of UTMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Utah Medical Products' stock price today?

One share of UTMD stock can currently be purchased for approximately $96.93.

How big of a company is Utah Medical Products?

Utah Medical Products has a market capitalization of $360.58 million and generates $46.90 million in revenue each year. Utah Medical Products employs 173 workers across the globe.View Additional Information About Utah Medical Products.

What is Utah Medical Products' official website?

The official website for Utah Medical Products is http://www.utahmed.com/.

How can I contact Utah Medical Products?

Utah Medical Products' mailing address is 7043 South 300 West, Midvale UT, 84047. The medical instruments supplier can be reached via phone at 801-566-1200.

MarketBeat Community Rating for Utah Medical Products (NASDAQ UTMD)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  132 (Vote Outperform)
Underperform Votes:  175 (Vote Underperform)
Total Votes:  307
MarketBeat's community ratings are surveys of what our community members think about Utah Medical Products and other stocks. Vote "Outperform" if you believe UTMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe UTMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel